The role of MAP kinases in the mechanism of EGF-mediated prevention of acetaldehyde-36 induced tight junction disruption was evaluated in Caco-2 cell monolayers. Pretreatment of cell 37 monolayers with EGF attenuated acetaldehyde-induced decrease in resistance, increase in inulin 38 permeability and redistribution of occludin, ZO-1, E-cadherin and β-catenin from the intercellular 39 junctions. EGF rapidly increased the levels of phospho-ERK1/2, phospho-p38MAPK and phospho-40 but not SB202190 and SP600125, prevented EGF effect on tyrosine-phosphorylation of occludin and 52 ZO-1, but not claudin-3, E-cadherin or β-catenin. These results indicate that EGF-mediated protection 53 of tight junctions from acetaldehyde requires the activity of ERK1/2, but not p38 MAPK or JNK1/2, 54 and that EGF-mediated protection of adherens junctions is independent of MAP kinase activities. 55 56
INTRODUCTION 70
Gastrointestinal mucosal barrier function prevents the diffusion of toxins, allergens and 71 pathogens from the lumen into the mucosal tissue. Tight junctions (TJs) are the epithelial structures 72 that act as physical and functional barrier against the paracellular penetration of macromolecules from 73 the lumen (3, 5) . Immediately basal to the TJ is the adherens junction (AJ), which is responsible for 74 intercellular adhesion between neighboring cells. Although they do not form a physical barrier for 75 diffusion of macromolecules, AJs indirectly regulate the integrity of TJs. Therefore, disruption of AJs 76 leads to disruption of TJs (38) . Both TJs and AJs associate with perijunctional actin cytoskeleton and 77 signaling molecules through multi protein complexes to form an integrated functional unit (25) . The 78 TJ is assembled by the organization of at least three types of transmembrane proteins, occludin, 79
Caco-2 cells at 60-70% confluence were transfected with commercially available pTet-on 159 vector (Clontech, Mountain View, CA), using lipofectamine LTX and plus reagent. The cells were 160 then selected with G0418 sulfate (700 μg/ml). After 14 days, the colonies of cells were cloned, 161 cultured and maintained in a lower concentration (350 μg/ml) of G0418 sulfate. These clones were 162 characterized by immunoblotting the whole cell lysate for Tet-R protein, and by luciferase assay for 163 doxycycline-induced expression. MEK1 constructs were transfected to pTet-On Caco-2 cells as 164 described above and the transfected cells were selected by incubation with hygromycin. Expression of 165 MEK1 was induced by incubation with doxycycline for 6-18 hours. Expression was assessed by 166 analysis for GFP by immunofluorescence staining. 167
Measurement of Transepithelial Electrical Resistance (TER) 168
TER was measured as described previously (28) 
Preparation of detergent-insoluble fractions 180
Triton-insoluble fractions were prepared as previously described (7). Cell monolayers in 181 Transwells (12 mm or 24 mm) were washed twice with ice-cold PBS, and incubated for 5 min with 182 cold lysis buffer-CS (20 mM Tris buffer containing 1.0% Triton-X100, 2 µg/ml leupeptin, 10 µg/ml 183 aprotinin, 10 µg/ml bestatin, 10 µg/ml pepstatin-A, 1 mM vanadate and 1 mM PMSF) at 4°C for 10 184 min. Cell lysates were centrifuged at 15,600 x g for 4 min at 4°C to sediment the high-density actin 185 cytoskeleton-rich fraction. Supernatant collected was Triton-soluble fraction. The pellet was 186 resuspended in 200 µl of lysis buffer-D (0.3% SDS in 10 mM Tris buffer, pH 7.4 10 mM sodium 187 fluoride 1 mM PMSF, 1 mM vanadate and 10 μl/ml protease inhibitor cocktail). Protein contents in 188 different fractions were measured by BCA method (Pierce Biotechnology Inc (Rockford, IL). Triton-189 insoluble and Triton-soluble fractions were mixed with equal volume of Laemmli's sample buffer (2x 190 concentrated), heated at 100°C for 5 min and stored until immunoblot analysis. 191
Confocal immunofluorescence microscopy 192
Under various experimental conditions, cell monolayers (6.5 mm/12 mm) were quickly washed 193 in cold PBS and fixed in 3% paraformaldehyde (pH 7) at room temperature for 15 min. antibodies. AlexaFlour-488-conjugated phalloidin was used to stain F-actin. The fluorescence was 200 examined by using a Zeiss LSM 5 laser scanning confocal microscope, and images from x-y sections 201
(1 µm) were collected using LSM 5 Pascal software. Images were stacked using the software, Image J 202 (NIH), and processed by Adobe Photoshop (Adobe Systems Inc., San Jose, CA). 203
Immunoprecipitation 204
Cell monolayers in Transwells (12 mm or 24 mm) were washed twice with ice-cold PBS, and 205 proteins were extracted with hot lysis buffer-D by heating at 100°C for 10 min as described previously 206 (32). Phospho-tyrosine was immunoprecipitated from the extracts as described previously (32) usingbiotin conjugated anti-phospho-tyrosine antibody.
Immunocomplexes were isolated using 208 streptavidin-agarose and immunoblotted for different TJ and AJ proteins using specific antibodies. 209
210

Immunoblot analysis 211
Cell extracts heated in Laemmli's sample buffer were separated by SDS-polyacrylamide gel 212 (7% gradient) electrophoresis and transferred to polyvinylidene diflouride membranes. Membranes 213 were blotted for p-ERK, p-JNK, ERK1/2, JNK1/2, p38MAPK and β-actin using specific antibodies in 214 combination with HRP-conjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG antibodies. The 215 blots were developed using ECL chemiluminescence method (Amersham, Arlington Heights, IL). 216
Statistics 217
Comparison between two groups was made by Student's t-tests for grouped data. Significance 218 in all tests was set at 95% or greater confidence level. 219
220
RESULTS
222
EGF activates different MAP kinases in Caco-2 cell monolayers. 223
To determine the effect of EGF on activation of MAP kinases, protein extracts prepared from 224 cells incubated with EGF for varying times were immunoblotted for p-ERK1/2, p-JNK1/2 and p-225 p38MAPK (activated MAP kinases). EGF treatment rapidly increased the levels of p-ERK1/2, p-226 JNK1/2 and p-p38MAPK (Fig. 1A ) predominantly in the detergent-soluble fractions. ERK activation 227 was much more rapid than JNK and p38MAPK activation. Peak levels of p-ERK, p-p38MAPK and p-228
JNK were recorded at 2 min, 5 min and 30 min, respectively. Activations of ERK and JNK1 were 229 transient with the activity fading by about 30 min, while p38MAPK activation sustained at least until 230 60 min. Significant level of p-ERK was present in the detergent-insoluble fraction, while p-p38MAPK 231 and p-JNK were undetectable in detergent-insoluble fraction. 232
233
Activity of ERK, but not p38MAPK or JNK, mediates prevention of acetaldehyde-induced barrier 234 dysfunction by EGF 235
Previous studies showed that EGF prevents acetaldehyde-induced increase in paracellular 236 permeability in Caco-2 monolayers (40). The present study confirms this effect of EGF on 237 acetaldehyde-induced decrease in TER (Fig. 1B ) and increase in inulin permeability (Fig. 1C) . The 238 present study also shows that pretreatment of cell monolayers with U0126 (ERK inhibitor) 239 significantly attenuates EGF-mediated prevention of acetaldehyde-induced changes in TER and inulin 240 permeability. Pretreatment of cells with SP600125 (JNK inhibitor) or SB202190 (p38MAPK 241 inhibitor) produced only a minor influence on EGF-mediated prevention of acetaldehyde-induced 242 changes in TER and inulin permeability. Control experiments showed that SB202190 and SP600125 243 slightly but significantly affected TER and/or inulin flux in the absence or presence of acetaldehyde. 244
While the effect of U0126 was dose-dependent, the minor effect of SP600125 or SB202190 on TER 245 and inulin flux was not dose-dependent (data not shown), indicating that the minor effects seen with 246 SP600125 and SB202190 are non-specific responses. EGF alone did not produce a significant change 247 in TER or inulin permeability, although a tendency for slight enhancement of barrier function was 248 often observed. 249
250
ERK activation is involved in EGF-mediated protection of TJs from acetaldehyde. 251
Confocal immunofluorescence microscopy showed that acetaldehyde treatment results in the 252 redistribution of occludin and ZO-1 from the intercellular junctions into the intracellular compartments 253 ( Fig. 2A) . Treatment of cell monolayers with EGF ameliorates this effect of acetaldehyde. 254
Pretreatment of cell monolayers with U0126, but not SB202190 or SP600125, attenuated EGF-255 mediated prevention of acetaldehyde-induced redistribution of occludin and ZO-1 from the 256 intercellular junctions ( Fig. 2A) . EGF treatment also attenuated acetaldehyde-induced redistribution of 257 E-cadherin and β-catenin from the intercellular junctions into the intracellular compartments (Fig. 2B) . 258
However, U0126, SB202190 or SP600125 did not alter EGF-mediated preservation of junctional 259 distribution of E-cadherin and β-catenin in acetaldehyde-treated cell monolayers (Fig. 2B) . 260
261
EGF prevents acetaldehyde-induced reorganization of actin cytoskeleton by an ERK-dependent 262 mechanism 263
Our previous study (40) showed that acetaldehyde induces reorganization of actin cytoskeleton 264 and EGF pretreatment prevented this effect of acetaldehyde. The present study confirms that EGF 265 protects the actin cytoskeletal organization at the apical (microvilli), middle (actomyosin ring) and 266 basal (stress fibers) regions of Caco-2 cells. In addition, the present study shows that pretreatment of 267 cells with U0126 prevents EGF-mediated preservation of actin cytoskeletal structure at the mid region 268 of cells (Fig. 3) . U0126 however did not prevent EGF effect on the actin cytoskeleton at the apical 269 region of the cells. SB202190 did not influence the EGF effect on actin cytoskeleton at all three 270 regions. SP600125 did prevent the EGF effect on actin cytoskeletal organization at the apical and 271 basal parts of the cell. On the other hand, SP600125 may have enhanced the actin organization at the 272 mid region of cells (Fig. 3) . Acetaldehyde treatment resulted in redistribution of ZO-1 (Fig. 4B ) from the intercellular 288 junctions in cells expressing empty vector or DN-MEK (Fig. 4B) , whereas junctional distribution of 289 ZO-1 (Fig. 4B ) was preserved in acetaldehyde-treated cells expressing WT-MEK and CA-MEK. EGF 290 treatment ameliorated acetaldehyde-induced disruption of junctional organization of ZO-1 in vector-291 transfected cells, whereas EGF failed to prevent acetaldehyde-induced redistribution of ZO-1 in cells 292 expressing DN-MEK (Fig. 4B) . Similarly, expression of WT-MEK and CA-MEK preserved 293 junctional distribution of occludin in acetaldehyde-treated cell monolayers, while the expression of 294 DN-MEK prevented EGF-mediated protection of occludin distribution from acetaldehyde (Fig. 5A) . 295
Expression of constitutively active MEK1 showed significantly higher level of p-ERK in the control 296 and EGF-treated cell monolayers (Fig. 5B) . The moderate difference in the p-ERK levels between 297 groups is likely due to homeostatic mechanisms within the cell to maintain ERK activity at low levels. 298
299
EGF prevents acetaldehyde-induced redistribution of E-cadherin and β-catenin by a mechanism
independent of ERK 301
Unlike occludin and ZO-1, E-cadherin was distributed at the intercellular junctions similarly in 302 vector-transfected cell monolayers and those that express WT-MEK, CA-MEK or DN-MEK (Fig. 6) . 303
Acetaldehyde induced redistribution of E-cadherin in cell monolayers expressing different forms of 304 MEK. Furthermore, EGF treatment ameliorated acetaldehyde-induced redistribution of E-cadherin in 305 vector, DN-MEK, WT-MEK or CA-MEK expressing cell monolayers, and no significant difference 306 was observed in the EGF effect on E-cadherin distribution in cells expressing different forms of MEK 307 (Fig. 6) . 308
309
EGF attenuates acetaldehyde-induced tyrosine-phosphorylation of occludin and ZO-1 by an ERK-310 dependent mechanism 311
Our previous study has showed that acetaldehyde induces tyrosine-phosphorylation of ZO-1, E-312 cadherin, and β-catenin (4). In the present study we investigated whether EGF prevents such tyrosine-313 phosphorylation of junctional proteins, and determined if ERK plays a role in this effect of EGF. The 314 results show that EGF treatment attenuates acetaldehyde-induced increase in tyrosine-phosphorylation 315 of occludin, ZO-1, E-cadherin and claudin-3, but tyrosine-phosphorylation of β-catenin was unaffected 316 (Fig. 7) . Pretreatment of cells with U0126, but not SB202190, attenuated EGF-mediated prevention of 317 tyrosine-phosphorylation of occludin ad ZO-1 (Fig. 7B) . U0126 however did not prevent the EGF 318 effect on tyrosine-phosphorylation of E-cadherin and claudin-3. 319 shows that EGF activates all three MAP kinases in differentiated Caco-2 cell monolayers, however 331 with some distinct temporal differences. ERK activation was most rapid and p38MAPK activation 332 was slow. Activation of ERK and JNK1 was transient, but p38MAPK activation sustained at least 333 until 60 min. Interestingly, EGF did not activate JNK2. Our recent study demonstrated that activation 334 of JNK2 disrupts TJs in the intestinal epithelium (35). Attenuation of EGF-mediated prevention of 335 acetaldehyde-induced TJ disruption and barrier dysfunction by U0126, but not by SB202190 or 336 SP600125, indicates that activation of ERK, but not p38MAPK and JNK, is required for EGF-337 mediated protection of TJs from acetaldehyde. Previous studies showed that ERK activation plays a 338 role in EGF-mediated protection of intestinal mucosa from various types of insults (6, 9, 13), whereas 339 p38MAPK activation is involved in disruption of TJs in the intestinal epithelia (12, 44) . A recent 340 study showed that JNK1 is involved in TJ disruption in T84 cell monolayers (26). But, our recent 341 study indicated that JNK2, but not JNK1, disrupts TJs in Caco-2 cell monolayers (35). The present 342 study suggests that ERK activation can be TJ-protective even in the face of p38MAPK and JNK 343 activation.
Prevention of acetaldehyde-induced redistribution of E-cadherin and β-catenin indicates that 345 EGF prevents acetaldehyde-induced disruption of AJs in Caco-2 cell monolayers. Although AJs do 346 not form a physical barrier to the diffusion of macromolecules, they indirectly regulate the integrity of 347
TJs. Disruption of AJs by removal of extracellular calcium has been repeatedly demonstrated to 348 disrupt the TJs as well (37, 41). Protection of AJs by EGF was previously shown in Caco-2 cell 349 monolayers treated with hydrogen peroxide or acetaldehyde (8, 36) . Interestingly, the present study 350
shows that EGF-induced prevention of redistribution of E-cadherin and β-catenin was unaffected by 351 U0126, SP600125 or SB202190. This observation indicates that EGF-mediated preservation of AJs 352 was independent of MAP kinase activities. 353
Our previous study showed that exposure to acetaldehyde causes reorganization of the actin 354 cytoskeletal architecture, and that EGF pretreatment preserves the actin cytoskeleton structure in 355 acetaldehyde-treated cell monolayers (40). In the differentiated intestinal epithelial cells, such as 356
Caco-2 cells, the organization of actin cytoskeleton is distinctly different at different levels of cell 357 height. At the apical region, F-actin filaments are organized as microvilli and terminal web, in the mid 358 region of cells it is organized to form actomyosin ring and the circumferential cortical network, and in 359 the basal region, actin is organized into stress fibers. Acetaldehyde treatment results in remodeling of 360 actin cytoskeleton at all regions and EGF preserves the native architecture of actin cytoskeleton in the 361 acetaldehyde-treated cells. However, the EGF effect was more prominent in the mid-region, 362 actomyosin ring, while its influence on preservation of stress fibers was moderate. Additionally, EGF 363 appears to modulate the microvillar organization of actin and its significance is unclear at this point. 364
TJ integrity is known to be dependent on the structure of actomyosin ring, and therefore preservation 365 of actomyosin structure by EGF is one of the likely mechanisms by which it prevents acetaldehyde-366 induced barrier disruption. The present study shows that inhibition of ERK activation by U0126 367 attenuates EGF effect on the actin cytoskeleton at the middle and basal regions of the cell, but it did 368 not alter the EGF-mediated preservation of actin cytoskeleton at the apical region of the cell.
Regulation of the actomyosin ring is likely to be mediated by EGF-induced ERK activation and thus 370 leading to the preservation of the barrier function. Inhibition of p38MAPK did not alter EGF effects 371 on the actin cytoskeleton at all levels, but inhibition of JNK prevented the EGF effect on actin 372 organization at the apical and basal regions of cell, but not at the actomyosin ring. JNK inhibition 373 appears to enhance actin organization at the mid region. Our recent study indicated that JNK activity 374 leads to destabilization of actin cytoskeleton. Therefore in the present study, it is likely that inhibition 375 of JNK activity lead to enhancement of cytoskeletal integrity. 376 MEK1 selectively activates ERK1/2 without any influence on p38MAPK or JNK1/2. Our 377 present study demonstrates that over expression of MEK1 or expression of constitutively active, CA-378 MEK1 attenuates acetaldehyde-induced redistribution of occludin and ZO-1 in the absence of EGF. 379
This observation indicates that prolonged activation of MEK1 can substitute for EGF in protecting the 380 TJ integrity in acetaldehyde-treated Caco-2 cell monolayers. Furthermore, our data also demonstrate 381 that expression of dominant negative DN-MEK1 attenuates EGF-mediated protection of TJ integrity 382 from acetaldehyde, further confirming that ERK signaling pathway is required for EGF-mediated 383 preservation of TJ integrity in acetaldehyde-treated cell monolayers. Our previous study demonstrated 384 that PLCγ and intracellular calcium-mediated activation of PKC isoforms also play a role in the 385 protection of TJs from acetaldehyde. Therefore, EGF appears to trigger activation of multiple 386 signaling pathways and influence different cellular targets that all converge at the TJs. There are 387 several ways to protect TJ integrity, such as enhancing the organization of actin ring, tightening AJs, 388 affecting TJs directly or intervening at various points in acetaldehyde-induced signaling pathways. 389
Further studies are necessary to determine whether these signaling pathways are interconnected or they 390 act independently on TJ integrity. 391
In our previous study we showed that acetaldehyde induces tyrosine-phosphorylation of TJ and 392 AJ proteins and that tyrosine kinase inhibitors prevent acetaldehyde-induced barrier disruption (4). 393
The present study confirms that acetaldehyde elevates tyrosine-phosphorylation of occludin, ZO-1, EProteins extracted from these cells were immunoblotted for p-ERK and total ERK. Bands for p- 
